Two current projects, which are a cost-sharing effort between 12 members of ReMDO and the Medical Technology Enterprise Consortium, aim to advance platform technologies that address regenerative medicine manufacturing challenges.

Universal Bioink

One project is developing a universal bioink with tunable mechanical properties for additive manufacturing (3D bioprinting) of implantable regenerative medicine clinical products.

Universal Cell Media

Another project is developing a universal cell media that will be a GMP-grade-defined formulation that can help accelerate cell therapy and tissue engineering manufacturing product development.